ZNF566
gene geneOn this page
Also known as FLJ14779MGC12515
Summary
ZNF566 (zinc finger protein 566, HGNC:25919) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 566 (Q969W8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in membrane. Predicted to be active in nucleus.
Source: NCBI Gene 84924 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_001145344
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25919 |
| Approved symbol | ZNF566 |
| Name | zinc finger protein 566 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14779, MGC12515 |
| Ensembl gene | ENSG00000186017 |
| Ensembl biotype | protein_coding |
| Entrez | 84924 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 12 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000392170, ENST00000424129, ENST00000427002, ENST00000434377, ENST00000452939, ENST00000460937, ENST00000472909, ENST00000480361, ENST00000493391, ENST00000494354, ENST00000587567, ENST00000915907, ENST00000915908, ENST00000915909, ENST00000915910, ENST00000968795
RefSeq mRNA: 5 — MANE Select: NM_001145344
NM_001145343, NM_001145344, NM_001145345, NM_001300970, NM_032838
CCDS: CCDS12494, CCDS46061, CCDS74346
Canonical transcript exons
ENST00000452939 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001115020 | 36472911 | 36473006 |
| ENSE00001600800 | 36489486 | 36489561 |
| ENSE00001796177 | 36445119 | 36450001 |
| ENSE00002494351 | 36473332 | 36473458 |
| ENSE00003668658 | 36476549 | 36476616 |
Expression profiles
Bgee: expression breadth ubiquitous, 192 present calls, max score 86.76.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.0556 / max 66.4794, expressed in 1557 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180676 | 2.3734 | 1139 |
| 180677 | 1.3790 | 790 |
| 180679 | 0.9774 | 549 |
| 180678 | 0.3257 | 148 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.76 | gold quality |
| cortical plate | UBERON:0005343 | 84.12 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.33 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.19 | gold quality |
| ventricular zone | UBERON:0003053 | 81.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.20 | gold quality |
| adrenal tissue | UBERON:0018303 | 79.04 | gold quality |
| colonic epithelium | UBERON:0000397 | 77.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.72 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 77.51 | gold quality |
| cerebellar cortex | UBERON:0002129 | 77.37 | gold quality |
| cerebellum | UBERON:0002037 | 76.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.89 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.74 | gold quality |
| muscle of leg | UBERON:0001383 | 75.44 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 75.35 | gold quality |
| gastrocnemius | UBERON:0001388 | 75.10 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 75.04 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.62 | gold quality |
| mucosa of stomach | UBERON:0001199 | 74.56 | gold quality |
| left uterine tube | UBERON:0001303 | 74.34 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.11 | gold quality |
| granulocyte | CL:0000094 | 73.99 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.81 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.61 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 73.57 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 73.56 | gold quality |
| lower esophagus | UBERON:0013473 | 73.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124858 | no | 136.36 |
| E-ANND-3 | no | 4.53 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
176 targeting ZNF566, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp566 | ENSMUSG00000078768 |
| rattus_norvegicus | Zfp566 | ENSRNOG00000048138 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 566 — Q969W8 (reviewed: Q969W8)
All UniProt accessions (5): Q969W8, B4DRR6, C9J2D3, C9J6X1, K7EQC1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q969W8-1 | 1 | yes |
| Q969W8-2 | 2 |
RefSeq proteins (5): NP_001138815, NP_001138816, NP_001138817, NP_001287899, NP_116227 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352, PF13465
UniProt features (13 total): zinc finger region 8, cross-link 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q969W8-F1 | 68.05 | 0.21 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 314, 328
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 115 (showing top):
MODULE_255, GCM_ZNF198, MODULE_317, GCM_PPM1D, GCM_SUFU, WEBER_METHYLATED_IN_COLON_CANCER, MODULE_69, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MODULE_37, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BANP_TARGET_GENES, IRF5_TARGET_GENES, NFE2L1_TARGET_GENES, SUPT16H_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
508 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF566 | PDZK1IP1 | Q13113 | 477 |
| ZNF566 | MBD3L3 | A6NE82 | 431 |
| ZNF566 | ZNF608 | Q9ULD9 | 375 |
| ZNF566 | C8orf89 | P0DMQ9 | 375 |
| ZNF566 | ZFHX3 | Q15911 | 370 |
| ZNF566 | SP140L | Q9H930 | 322 |
| ZNF566 | ZNF804A | Q7Z570 | 311 |
| ZNF566 | PITX2 | Q99697 | 310 |
| ZNF566 | GMEB1 | Q9Y692 | 305 |
| ZNF566 | ENTPD6 | O75354 | 290 |
| ZNF566 | INO80E | Q8NBZ0 | 290 |
| ZNF566 | FAM133A | Q8N9E0 | 276 |
| ZNF566 | CMC2 | Q9NRP2 | 266 |
| ZNF566 | ETV7 | Q9Y603 | 256 |
| ZNF566 | SACK1B | Q5T0W9 | 248 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EXOC8 | ZNF566 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGOHB | ZNF566 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF566 | MAGOHB | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF566 | KIF9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF566 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| Trim28 | FTH1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF566 | KIF2C | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPATA20 | SCRN3 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF566 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| SPATA20 | HDAC4 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM63 | ZNF566 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TRIM55 | ZNF566 | psi-mi:“MI:0915”(physical association) | 0.000 |
| KIF9 | ZNF566 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Synthetic Lethality), ZNF566 (Two-hybrid), ZNF566 (Two-hybrid), ZNF566 (Two-hybrid), ZNF566 (Two-hybrid), ZNF566 (Two-hybrid), ZNF566 (Proximity Label-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS), ZNF566 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1079 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36450002:C:CC | acceptor_gain | 1.0000 |
| 19:36473326:CCTTA:C | donor_loss | 1.0000 |
| 19:36473327:CTT:C | donor_loss | 1.0000 |
| 19:36473328:TTA:T | donor_loss | 1.0000 |
| 19:36473329:TA:T | donor_loss | 1.0000 |
| 19:36473330:A:AT | donor_loss | 1.0000 |
| 19:36473330:AC:A | donor_gain | 1.0000 |
| 19:36473331:CC:C | donor_gain | 1.0000 |
| 19:36449997:CAGGA:C | acceptor_gain | 0.9900 |
| 19:36449998:AGGA:A | acceptor_gain | 0.9900 |
| 19:36449999:GGA:G | acceptor_gain | 0.9900 |
| 19:36449999:GGAC:G | acceptor_loss | 0.9900 |
| 19:36450000:GA:G | acceptor_gain | 0.9900 |
| 19:36450000:GAC:G | acceptor_loss | 0.9900 |
| 19:36450001:AC:A | acceptor_loss | 0.9900 |
| 19:36473011:T:C | acceptor_gain | 0.9900 |
| 19:36473330:A:AC | donor_gain | 0.9900 |
| 19:36473331:C:CC | donor_gain | 0.9900 |
| 19:36473456:CTC:C | acceptor_gain | 0.9900 |
| 19:36473458:CCTGG:C | acceptor_loss | 0.9900 |
| 19:36473460:T:C | acceptor_loss | 0.9900 |
| 19:36476612:TAGAG:T | acceptor_gain | 0.9900 |
| 19:36476617:C:CC | acceptor_gain | 0.9900 |
| 19:36481737:A:T | acceptor_gain | 0.9900 |
| 19:36450003:T:C | acceptor_loss | 0.9800 |
| 19:36473011:T:TC | acceptor_gain | 0.9800 |
| 19:36473459:C:CC | acceptor_gain | 0.9800 |
| 19:36476542:ATCT:A | donor_loss | 0.9800 |
| 19:36476543:TCTCA:T | donor_loss | 0.9800 |
| 19:36476544:CTCAC:C | donor_loss | 0.9800 |
AlphaMissense
1558 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36473377:A:C | Y31D | 0.981 |
| 19:36473400:A:G | L23P | 0.979 |
| 19:36473408:C:A | W20C | 0.977 |
| 19:36473408:C:G | W20C | 0.977 |
| 19:36449610:A:C | F208L | 0.976 |
| 19:36449610:A:T | F208L | 0.976 |
| 19:36449612:A:G | F208L | 0.976 |
| 19:36473410:A:G | W20R | 0.974 |
| 19:36473410:A:T | W20R | 0.974 |
| 19:36473424:A:G | F15S | 0.969 |
| 19:36473343:A:G | L42P | 0.967 |
| 19:36449585:G:C | H217D | 0.963 |
| 19:36449583:A:C | H217Q | 0.955 |
| 19:36449583:A:T | H217Q | 0.955 |
| 19:36473376:T:G | Y31S | 0.952 |
| 19:36449553:A:C | F227L | 0.949 |
| 19:36449553:A:T | F227L | 0.949 |
| 19:36449555:A:G | F227L | 0.949 |
| 19:36473423:G:C | F15L | 0.947 |
| 19:36473423:G:T | F15L | 0.947 |
| 19:36473425:A:G | F15L | 0.947 |
| 19:36473409:C:G | W20S | 0.943 |
| 19:36449581:T:G | Q218P | 0.942 |
| 19:36473444:G:C | F8L | 0.940 |
| 19:36473444:G:T | F8L | 0.940 |
| 19:36473446:A:G | F8L | 0.940 |
| 19:36449539:C:G | C232S | 0.938 |
| 19:36449540:A:T | C232S | 0.938 |
| 19:36473377:A:T | Y31N | 0.938 |
| 19:36449538:A:C | C232W | 0.937 |
dbSNP variants (sampled 300 via entrez): RS1000054786 (19:36469656 G>A), RS1000104729 (19:36459499 C>T), RS1000282859 (19:36453117 CA>C,CAA,CAAA), RS1000461785 (19:36449706 A>G), RS1000612846 (19:36477778 T>C), RS1000663525 (19:36482148 C>A), RS1000666625 (19:36477468 A>T), RS1000690060 (19:36465053 C>T), RS1000777970 (19:36482306 C>T), RS1000781060 (19:36478957 G>A), RS1000873400 (19:36483984 T>C,G), RS1000940792 (19:36467924 G>A), RS1001043749 (19:36446534 C>G), RS1001060139 (19:36468097 A>G), RS1001069610 (19:36489766 C>A,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| coumarin | increases phosphorylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Vorinostat | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Nickel | decreases expression | 1 |
| Oxygen | decreases expression | 1 |
| Testosterone | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.